The identification of inhibitors of nerve growth factor and brain-derived neurotrophic factor
Chronic pain affects up to 43% of the UK population, with 12% reporting moderate to severely limiting chronic pain.1-2 This incidence rate rises with age, with 62% of over 75s being diagnosed.1 The current standard of care for chronic pain almost exclusively involves COX-1, COX-2 or μ-opioid recepto...
Main Author: | Ingram, James David |
---|---|
Other Authors: | Tavassoli, Ali |
Published: |
University of Southampton
2017
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.749765 |
Similar Items
-
Dehydroepiandrosterone Stimulates Nerve Growth Factor and Brain Derived Neurotrophic Factor in Cortical Neurons
by: Anahita Rahmani, et al.
Published: (2013-01-01) -
Association of brain-derived neurotrophic factor and nerve growth factor gene polymorphisms with susceptibility to migraine
by: Coskun S, et al.
Published: (2016-07-01) -
Exploring Serum Levels of Brain Derived Neurotrophic Factor and Nerve Growth Factor Across Glaucoma Stages.
by: Francesco Oddone, et al.
Published: (2017-01-01) -
Prediction of the binding free energies of inhibitors of epidermal growth factor receptor kinase and the identification of the dynamics thereof
by: Bull, Christopher
Published: (2013) -
Brain Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor-Transfected Bone Mesenchymal Stem Cells for the Repair of Periphery Nerve Injury
by: Qiang Zhang, et al.
Published: (2020-07-01)